PRECIPIO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PRECIPIO, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-09-30 was 1.23K shares.
- PRECIPIO, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2013-09-30 was 0.00 shares.
- PRECIPIO, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2013-06-30 was 0.00 shares.
- PRECIPIO, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2013-03-31 was 0.00 shares.
- PRECIPIO, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2012 was 20.00K shares, a 33.33% decline from fiscal 2011.
- PRECIPIO, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2011 was 30.00K shares, a 70.00% decline from fiscal 2010.
- PRECIPIO, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2010 was 100.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2021-09-30 | 1.23K shares 10-Q · filed 2022-11-10 | |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | 0.00 shares derived: sum of 4 quarters · filed 2013-11-14 |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | 0.00 shares derived: sum of 4 quarters · filed 2013-08-08 |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-09 | |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | 20.00K shares 10-K · filed 2013-03-14 |
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | |
| 2011-12-31 | 30.00K shares 10-K · filed 2013-03-14 | |
| 2010-12-31 | 100.00K shares 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |